Approval · Notice of Compliance 30792 · 2023
TECFIDERA: Notice of Compliance 30792
Issued May 18, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30792
- Date
- May 18, 2023
- Company
- Biogen Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates related to lymphocyte recovery information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TECFIDERA | Not yet assigned | — |
Medicinal ingredients
- DIMETHYL FUMARATE 120 MG per CAP
- DIMETHYL FUMARATE 240 MG per CAP